ORIGINAL RESEARCH
Published on 27 Mar 2025
Neoadjuvant immunotherapy for NSCLC: superior combination strategies, optimal treatment cycles, and predictive indicators from a Bayesian meta-analysis
doi 10.3389/fimmu.2025.1548665
- 113 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- The Application of Immune Checkpoint Inhibitors Combined with Chemotherapy in Tumor Immunotherapy
The Application of Immune Checkpoint Inhibitors Combined with Chemotherapy in Tumor Immunotherapy
1,448
Total downloads
5,868
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Accepted on 20 Mar 2025
Comparison of immunotherapy based total neoadjuvant therapy or standard neoadjuvant chemoradiation for locally advanced rectal cancer: a multi-institutional retrospective study
doi 10.3389/fimmu.2025.1513716
ORIGINAL RESEARCH
Accepted on 17 Mar 2025
Efficacy and safety of Geptanolimab in previously treated PD-L1-Positive recurrent or metastatic cervical cancer: a multi-center openlabel, single-arm, phase Ⅱ study
doi 10.3389/fonc.2025.1528276
REVIEW
Accepted on 12 Mar 2025
Efficacy and safety of programmed cell death protein-1 inhibitor for first-line therapy of advanced gastric cancer or gastroesophageal junction cancer: a network meta-analysis
doi 10.3389/fimmu.2025.1500954
CASE REPORT
Published on 10 Mar 2025
Case Report: Metastatic succinate dehydrogenase–deficient gastrointestinal stromal tumor treated with chemotherapy and immune checkpoint inhibitor
doi 10.3389/fonc.2025.1549232
- 481 views
ORIGINAL RESEARCH
Published on 14 Feb 2025
Efficacy and safety of sintilimab combined with trastuzumab and chemotherapy in HER2-positive advanced gastric or gastroesophageal junction cancer
doi 10.3389/fimmu.2025.1545304
- 474 views
BRIEF RESEARCH REPORT
Published on 31 Jan 2025
The systemic oxidative stress index predicts clinical outcomes of esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapy
doi 10.3389/fimmu.2025.1535507
- 602 views
CASE REPORT
Published on 23 Jan 2025
Combination chemotherapy with sintilimab for treatment of a male patient with primary pulmonary choriocarcinoma: a case report and literature review
doi 10.3389/fimmu.2025.1523316
- 675 views
CASE REPORT
Published on 24 Dec 2024
Case report: Aggressive NSCLC with partial BRG-1 deficiency and KRAS G12C mutation: a case study and treatment challenges
doi 10.3389/fonc.2024.1515240
- 737 views
CASE REPORT
Published on 11 Dec 2024
Newly emerged ROS1 rearrangement in a patient with lung adenocarcinoma following resistance to immune checkpoint inhibitors: a case report
doi 10.3389/fonc.2024.1507658
- 579 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: